# NIH Reporter #1P50HD123367-01

In vitro, ex vivo and in vivo Efficacy Core

**Recipient:** WEILL MEDICAL COLL OF CORNELL UNIV

**Award Amount:** $420,951.00
**Ceiling:** $420,951.00

**Awarded:** September 10, 2026

**Identifier:** 1P50HD123367-01

The NIH award supports a Weill Cornell core that evaluates soluble adenylyl cyclase inhibitor compounds as part of research toward an on-demand, nonhormonal male contraceptive.

### Description

Funding for the Weill Cornell Medicine Contraception Research Center Technical Core to support assays evaluating the in vitro, ex vivo, and in vivo efficacy of soluble adenylyl cyclase inhibitor compounds and related formulations and metabolites.

[View original record](https://reporter.nih.gov/search/J7l2tQ4hHkqRePwGq3m5kA/project-details/11451841)